APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granisetron

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Granisetron Market Outlook and Growth Opportunities 2026

22 December 2025201 pages

Choose your research edition.

Industry ResearchGranisetron Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Granisetron Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Granisetron Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granisetron Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Granisetron Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Granisetron market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Granisetron is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Granisetron market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Granisetron market include Kyowa Kirin, Teva, Sandoz, Mylan, Fresenius Kabi, Wockhardt, Taro Pharmaceutical, Natco Pharma and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Granisetron market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Granisetron and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Granisetron revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Granisetron market.

Granisetron Segment by Company

Kyowa Kirin

Teva

Sandoz

Mylan

Fresenius Kabi

Wockhardt

Taro Pharmaceutical

Natco Pharma

Hikma Pharmaceuticals

Heron Therapeutics

Dr.Reddy's

Cipla

Bluepharma

Aurobindo

APOTEX

Akorn

Granisetron Segment by Type

Injection

Transdermal system

Oral

Granisetron Segment by Application

Chemotherapy

Post operative

Granisetron Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Granisetron status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Granisetron key companies, revenue, market share, and recent developments.

3. To split the Granisetron breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Granisetron market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Granisetron significant trends, drivers, influence factors in global and regions.

6. To analyze Granisetron competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granisetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granisetron and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granisetron.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Granisetron industry.

Chapter 3: Detailed analysis of Granisetron company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Granisetron in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Granisetron in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Granisetron Industry Trends Table 2. Granisetron Industry Drivers Table 3. Granisetron Industry Opportunities and Challenges Table 4. Granisetron Industry Restraints Table 5. Global Granisetron Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Granisetron Revenue Share by Company (2021-2026) Table 7. Global Granisetron Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Granisetron Key Company Manufacturing Base & Headquarters Table 9. Global Granisetron Company, Product Type & Application Table 10. Global Granisetron Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Granisetron by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Injection Table 15. Significant Companies of Transdermal system Table 16. Significant Companies of Oral Table 17. Global Granisetron Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Granisetron Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Granisetron Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Granisetron Sales Value Share by Type (2021-2026) Table 21. Global Granisetron Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Chemotherapy Table 23. Significant Companies of Post operative Table 24. Global Granisetron Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Granisetron Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Granisetron Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Granisetron Sales Value Share by Application (2021-2026) Table 28. Global Granisetron Sales Value Share by Application (2027-2032) Table 29. Global Granisetron Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Granisetron Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Granisetron Sales Value Share by Region (2021-2026) Table 32. Global Granisetron Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Granisetron Sales Value Share by Region (2027-2032) Table 34. Global Granisetron Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Granisetron Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Granisetron Sales Value Market Share by Country (2021-2026) Table 37. Global Granisetron Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Granisetron Sales Value Market Share by Country (2027-2032) Table 39. Kyowa Kirin Company Information Table 40. Kyowa Kirin Business Overview Table 41. Kyowa Kirin Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Kyowa Kirin Granisetron Product Portfolio Table 43. Kyowa Kirin Recent Development Table 44. Teva Company Information Table 45. Teva Business Overview Table 46. Teva Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Teva Granisetron Product Portfolio Table 48. Teva Recent Development Table 49. Sandoz Company Information Table 50. Sandoz Business Overview Table 51. Sandoz Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Sandoz Granisetron Product Portfolio Table 53. Sandoz Recent Development Table 54. Mylan Company Information Table 55. Mylan Business Overview Table 56. Mylan Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Mylan Granisetron Product Portfolio Table 58. Mylan Recent Development Table 59. Fresenius Kabi Company Information Table 60. Fresenius Kabi Business Overview Table 61. Fresenius Kabi Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Fresenius Kabi Granisetron Product Portfolio Table 63. Fresenius Kabi Recent Development Table 64. Wockhardt Company Information Table 65. Wockhardt Business Overview Table 66. Wockhardt Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Wockhardt Granisetron Product Portfolio Table 68. Wockhardt Recent Development Table 69. Taro Pharmaceutical Company Information Table 70. Taro Pharmaceutical Business Overview Table 71. Taro Pharmaceutical Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Taro Pharmaceutical Granisetron Product Portfolio Table 73. Taro Pharmaceutical Recent Development Table 74. Natco Pharma Company Information Table 75. Natco Pharma Business Overview Table 76. Natco Pharma Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Natco Pharma Granisetron Product Portfolio Table 78. Natco Pharma Recent Development Table 79. Hikma Pharmaceuticals Company Information Table 80. Hikma Pharmaceuticals Business Overview Table 81. Hikma Pharmaceuticals Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Hikma Pharmaceuticals Granisetron Product Portfolio Table 83. Hikma Pharmaceuticals Recent Development Table 84. Heron Therapeutics Company Information Table 85. Heron Therapeutics Business Overview Table 86. Heron Therapeutics Granisetron Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Heron Therapeutics Granisetron Product Portfolio Table 88. Heron Therapeutics Recent Development Table 89. Dr.Reddy's Company Information Table 90. Dr.Reddy's Business Overview Table 91. Dr.Reddy's Granisetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Dr.Reddy's Granisetron Product Portfolio Table 93. Dr.Reddy's Recent Development Table 94. Cipla Company Information Table 95. Cipla Business Overview Table 96. Cipla Granisetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Cipla Granisetron Product Portfolio Table 98. Cipla Recent Development Table 99. Bluepharma Company Information Table 100. Bluepharma Business Overview Table 101. Bluepharma Granisetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Bluepharma Granisetron Product Portfolio Table 103. Bluepharma Recent Development Table 104. Aurobindo Company Information Table 105. Aurobindo Business Overview Table 106. Aurobindo Granisetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Aurobindo Granisetron Product Portfolio Table 108. Aurobindo Recent Development Table 109. APOTEX Company Information Table 110. APOTEX Business Overview Table 111. APOTEX Granisetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. APOTEX Granisetron Product Portfolio Table 113. APOTEX Recent Development Table 114. Akorn Company Information Table 115. Akorn Business Overview Table 116. Akorn Granisetron Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Akorn Granisetron Product Portfolio Table 118. Akorn Recent Development Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Granisetron Product Image Figure 2. Global Granisetron Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granisetron Market Size (2021-2032) & (US$ Million) Figure 4. Global Granisetron Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Injection Image Figure 8. Transdermal system Image Figure 9. Oral Image Figure 10. Global Granisetron Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Granisetron Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Granisetron Sales Value Share by Type (2021-2032) Figure 13. Chemotherapy Image Figure 14. Post operative Image Figure 15. Global Granisetron Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Granisetron Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Granisetron Sales Value Share by Application (2021-2032) Figure 18. Global Granisetron Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Granisetron Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Granisetron Sales Value (2021-2032) & (US$ Million) Figure 21. North America Granisetron Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Granisetron Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Granisetron Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Granisetron Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Granisetron Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Granisetron Sales Value (2021-2032) & (US$ Million) Figure 27. South America Granisetron Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Granisetron Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Granisetron Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Granisetron Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Granisetron Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Granisetron Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Transdermal system
  • Oral
Applications
  • Chemotherapy
  • Post operative
Companies covered
  • Kyowa Kirin
  • Teva
  • Sandoz
  • Mylan
  • Fresenius Kabi
  • Wockhardt
  • Taro Pharmaceutical
  • Natco Pharma
  • Hikma Pharmaceuticals
  • Heron Therapeutics
  • Dr.Reddy's
  • Cipla
  • Bluepharma
  • Aurobindo
  • APOTEX
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Granisetron Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Granisetron Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Granisetron Market Dynamics
  1. 2.1 Granisetron Industry Trends
  2. 2.2 Granisetron Industry Drivers
  3. 2.3 Granisetron Industry Opportunities and Challenges
  4. 2.4 Granisetron Industry Restraints
3 Granisetron Market by Company
  1. 3.1 Global Granisetron Company Revenue Ranking in 2025
  2. 3.2 Global Granisetron Revenue by Company (2021-2026)
  3. 3.3 Global Granisetron Company Ranking (2024-2026)
  4. 3.4 Global Granisetron Company Manufacturing Base and Headquarters
  5. 3.5 Global Granisetron Company Product Type and Application
  6. 3.6 Global Granisetron Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Granisetron Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Granisetron Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Granisetron Market by Type
  1. 4.1 Granisetron Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Transdermal system
  4. 4.1.3 Oral
  5. 4.2 Global Granisetron Sales Value by Type
  6. 4.2.1 Global Granisetron Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Granisetron Sales Value by Type (2021-2032)
  8. 4.2.3 Global Granisetron Sales Value Share by Type (2021-2032)
5 Granisetron Market by Application
  1. 5.1 Granisetron Application Introduction
  2. 5.1.1 Chemotherapy
  3. 5.1.2 Post operative
  4. 5.2 Global Granisetron Sales Value by Application
  5. 5.2.1 Global Granisetron Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Granisetron Sales Value by Application (2021-2032)
  7. 5.2.3 Global Granisetron Sales Value Share by Application (2021-2032)
6 Granisetron Regional Value Analysis
  1. 6.1 Global Granisetron Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Granisetron Sales Value by Region (2021-2032)
  3. 6.2.1 Global Granisetron Sales Value by Region: 2021-2026
  4. 6.2.2 Global Granisetron Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Granisetron Sales Value (2021-2032)
  7. 6.3.2 North America Granisetron Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Granisetron Sales Value (2021-2032)
  10. 6.4.2 Europe Granisetron Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Granisetron Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Granisetron Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Granisetron Sales Value (2021-2032)
  16. 6.6.2 South America Granisetron Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Granisetron Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Granisetron Sales Value Share by Country, 2025 VS 2032
7 Granisetron Country-level Value Analysis
  1. 7.1 Global Granisetron Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Granisetron Sales Value by Country (2021-2032)
  3. 7.2.1 Global Granisetron Sales Value by Country (2021-2026)
  4. 7.2.2 Global Granisetron Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Granisetron Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Granisetron Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Granisetron Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Granisetron Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Granisetron Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Granisetron Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Granisetron Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Granisetron Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Granisetron Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Granisetron Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Granisetron Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Granisetron Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Granisetron Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Granisetron Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Granisetron Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Granisetron Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Granisetron Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Granisetron Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Granisetron Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Granisetron Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Granisetron Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Granisetron Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Granisetron Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Granisetron Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Granisetron Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Granisetron Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Granisetron Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Granisetron Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Granisetron Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Granisetron Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Granisetron Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Granisetron Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Granisetron Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Granisetron Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Granisetron Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Granisetron Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Granisetron Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Granisetron Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Granisetron Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Granisetron Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Granisetron Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Granisetron Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Granisetron Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Granisetron Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Granisetron Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Granisetron Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Granisetron Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Granisetron Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Granisetron Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Granisetron Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Granisetron Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Granisetron Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Granisetron Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Granisetron Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Granisetron Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Granisetron Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Granisetron Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Granisetron Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Granisetron Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Granisetron Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Granisetron Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Granisetron Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Granisetron Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Granisetron Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Granisetron Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Granisetron Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Granisetron Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Granisetron Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Granisetron Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Granisetron Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Granisetron Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Granisetron Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Granisetron Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Granisetron Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Granisetron Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Granisetron Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Granisetron Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Granisetron Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Granisetron Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Granisetron Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Granisetron Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Granisetron Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Granisetron Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Granisetron Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kyowa Kirin
  2. 8.1.1 Kyowa Kirin Company Information
  3. 8.1.2 Kyowa Kirin Business Overview
  4. 8.1.3 Kyowa Kirin Granisetron Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Kyowa Kirin Granisetron Product Portfolio
  6. 8.1.5 Kyowa Kirin Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Granisetron Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Granisetron Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Granisetron Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Granisetron Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Granisetron Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Granisetron Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Fresenius Kabi
  26. 8.5.1 Fresenius Kabi Company Information
  27. 8.5.2 Fresenius Kabi Business Overview
  28. 8.5.3 Fresenius Kabi Granisetron Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius Kabi Granisetron Product Portfolio
  30. 8.5.5 Fresenius Kabi Recent Developments
  31. 8.6 Wockhardt
  32. 8.6.1 Wockhardt Company Information
  33. 8.6.2 Wockhardt Business Overview
  34. 8.6.3 Wockhardt Granisetron Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Wockhardt Granisetron Product Portfolio
  36. 8.6.5 Wockhardt Recent Developments
  37. 8.7 Taro Pharmaceutical
  38. 8.7.1 Taro Pharmaceutical Company Information
  39. 8.7.2 Taro Pharmaceutical Business Overview
  40. 8.7.3 Taro Pharmaceutical Granisetron Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Taro Pharmaceutical Granisetron Product Portfolio
  42. 8.7.5 Taro Pharmaceutical Recent Developments
  43. 8.8 Natco Pharma
  44. 8.8.1 Natco Pharma Company Information
  45. 8.8.2 Natco Pharma Business Overview
  46. 8.8.3 Natco Pharma Granisetron Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Natco Pharma Granisetron Product Portfolio
  48. 8.8.5 Natco Pharma Recent Developments
  49. 8.9 Hikma Pharmaceuticals
  50. 8.9.1 Hikma Pharmaceuticals Company Information
  51. 8.9.2 Hikma Pharmaceuticals Business Overview
  52. 8.9.3 Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hikma Pharmaceuticals Granisetron Product Portfolio
  54. 8.9.5 Hikma Pharmaceuticals Recent Developments
  55. 8.10 Heron Therapeutics
  56. 8.10.1 Heron Therapeutics Company Information
  57. 8.10.2 Heron Therapeutics Business Overview
  58. 8.10.3 Heron Therapeutics Granisetron Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Heron Therapeutics Granisetron Product Portfolio
  60. 8.10.5 Heron Therapeutics Recent Developments
  61. 8.11 Dr.Reddy's
  62. 8.11.1 Dr.Reddy's Company Information
  63. 8.11.2 Dr.Reddy's Business Overview
  64. 8.11.3 Dr.Reddy's Granisetron Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dr.Reddy's Granisetron Product Portfolio
  66. 8.11.5 Dr.Reddy's Recent Developments
  67. 8.12 Cipla
  68. 8.12.1 Cipla Company Information
  69. 8.12.2 Cipla Business Overview
  70. 8.12.3 Cipla Granisetron Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cipla Granisetron Product Portfolio
  72. 8.12.5 Cipla Recent Developments
  73. 8.13 Bluepharma
  74. 8.13.1 Bluepharma Company Information
  75. 8.13.2 Bluepharma Business Overview
  76. 8.13.3 Bluepharma Granisetron Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bluepharma Granisetron Product Portfolio
  78. 8.13.5 Bluepharma Recent Developments
  79. 8.14 Aurobindo
  80. 8.14.1 Aurobindo Company Information
  81. 8.14.2 Aurobindo Business Overview
  82. 8.14.3 Aurobindo Granisetron Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Granisetron Product Portfolio
  84. 8.14.5 Aurobindo Recent Developments
  85. 8.15 APOTEX
  86. 8.15.1 APOTEX Company Information
  87. 8.15.2 APOTEX Business Overview
  88. 8.15.3 APOTEX Granisetron Revenue and Gross Margin (2021-2026)
  89. 8.15.4 APOTEX Granisetron Product Portfolio
  90. 8.15.5 APOTEX Recent Developments
  91. 8.16 Akorn
  92. 8.16.1 Akorn Company Information
  93. 8.16.2 Akorn Business Overview
  94. 8.16.3 Akorn Granisetron Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Akorn Granisetron Product Portfolio
  96. 8.16.5 Akorn Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst